Exhibitors On Demand
NBTS is unrelentingly committed to providing brain tumor patients and caregivers with the support, education and resources they need to feel empowered and prepared as they navigate their brain tumor journey. Putting patients first during these uncertain times of COVID-19, NBTS has stepped up the programs it offers, including a weekly updated webpage, COVID-19: What our Brain Tumor Community Needs to Know, and announcing its newest addition, the Personalized Support and Navigation Program. Patients and caregivers can connect directly with NBTS Patient Navigator at email@example.com. Other initiatives offered to the brain tumor community include Brain Tumor Experience resources, Clinical Trial Finder, and monthly Brain Tumor Support Conversations.
Neurelis, Inc. is an innovation-driven neuroscience company focused on providing solutions for unmet medical needs. We have reached a milestone in patient care with the company’s first FDA-approved treatment. For more information, please visit www.neurelis.com or our product page.
NEURELIS and the NEURELIS logo are registered trademarks of Neurelis, Inc.
Neurocrine Biosciences is a neuroscience-focused biopharmaceutical company with more than 25 years of experience discovering and developing life-changing treatments for people with serious, challenging, and under-addressed neurological, endocrine, and psychiatric disorders. Visit www.neurocrinemedical.com.